| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 35 | 2024 | 7259 | 3.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 19 | 2023 | 1547 | 3.070 |
Why?
|
| Apoptosis | 42 | 2023 | 7842 | 2.180 |
Why?
|
| Apoptosis Regulatory Proteins | 9 | 2022 | 621 | 1.790 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 11 | 2013 | 124 | 1.760 |
Why?
|
| Inhibitor of Apoptosis Proteins | 9 | 2014 | 202 | 1.530 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 11 | 2021 | 2635 | 1.480 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 7 | 2024 | 1009 | 1.480 |
Why?
|
| Fusion Proteins, bcr-abl | 9 | 2020 | 1143 | 1.390 |
Why?
|
| Blast Crisis | 8 | 2021 | 587 | 1.330 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 7 | 2023 | 289 | 1.320 |
Why?
|
| Sulfonamides | 8 | 2024 | 1930 | 1.200 |
Why?
|
| Phenanthrenes | 5 | 2020 | 43 | 1.200 |
Why?
|
| Antineoplastic Agents | 23 | 2023 | 14651 | 1.180 |
Why?
|
| Diterpenes | 5 | 2020 | 117 | 1.150 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 298 | 1.060 |
Why?
|
| Mitochondrial Proteins | 5 | 2019 | 385 | 1.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 7 | 2023 | 842 | 1.030 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2022 | 5422 | 1.020 |
Why?
|
| Cytoskeletal Proteins | 2 | 2019 | 544 | 0.980 |
Why?
|
| Microtubule-Associated Proteins | 6 | 2007 | 533 | 0.910 |
Why?
|
| Tumor Suppressor Protein p53 | 11 | 2024 | 3671 | 0.910 |
Why?
|
| Caspases | 6 | 2016 | 687 | 0.900 |
Why?
|
| Gene Expression Regulation, Leukemic | 8 | 2021 | 582 | 0.860 |
Why?
|
| Biomimetic Materials | 1 | 2022 | 39 | 0.810 |
Why?
|
| Cell Line, Tumor | 30 | 2023 | 14888 | 0.810 |
Why?
|
| Protein Kinase Inhibitors | 11 | 2022 | 4964 | 0.790 |
Why?
|
| Neoplastic Stem Cells | 6 | 2020 | 1469 | 0.780 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 6 | 2023 | 529 | 0.710 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 1599 | 0.690 |
Why?
|
| Piperazines | 8 | 2015 | 2147 | 0.680 |
Why?
|
| Leukemia, Myeloid | 6 | 2019 | 994 | 0.680 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2020 | 116 | 0.680 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 1295 | 0.670 |
Why?
|
| Muscle Proteins | 2 | 2014 | 561 | 0.640 |
Why?
|
| Antigens, CD34 | 4 | 2016 | 643 | 0.610 |
Why?
|
| Tumor Microenvironment | 3 | 2019 | 3026 | 0.610 |
Why?
|
| Dinoprostone | 1 | 2019 | 222 | 0.600 |
Why?
|
| Cell Proliferation | 13 | 2021 | 7308 | 0.590 |
Why?
|
| Mice | 22 | 2023 | 36058 | 0.570 |
Why?
|
| Dipeptides | 2 | 2014 | 97 | 0.570 |
Why?
|
| Antimetabolites, Antineoplastic | 5 | 2019 | 1351 | 0.570 |
Why?
|
| Leukemia | 6 | 2024 | 1721 | 0.560 |
Why?
|
| Antineoplastic Agents, Alkylating | 3 | 2009 | 609 | 0.550 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 498 | 0.550 |
Why?
|
| MAP Kinase Signaling System | 2 | 2014 | 889 | 0.540 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2017 | 163 | 0.530 |
Why?
|
| Drug Synergism | 8 | 2021 | 1364 | 0.530 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2024 | 2624 | 0.530 |
Why?
|
| Wnt Signaling Pathway | 2 | 2020 | 445 | 0.520 |
Why?
|
| beta Catenin | 2 | 2020 | 692 | 0.520 |
Why?
|
| Animals | 30 | 2023 | 62826 | 0.520 |
Why?
|
| Caspase 8 | 2 | 2014 | 147 | 0.510 |
Why?
|
| Pyrimidines | 7 | 2015 | 3664 | 0.500 |
Why?
|
| Imatinib Mesylate | 8 | 2020 | 1690 | 0.500 |
Why?
|
| Cell Survival | 9 | 2018 | 3075 | 0.490 |
Why?
|
| Tumor Cells, Cultured | 7 | 2020 | 5804 | 0.470 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2020 | 3934 | 0.470 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2020 | 9101 | 0.470 |
Why?
|
| Oligonucleotides | 3 | 2013 | 245 | 0.460 |
Why?
|
| Mice, SCID | 5 | 2020 | 1851 | 0.420 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2023 | 380 | 0.400 |
Why?
|
| NF-kappa B | 2 | 2016 | 1569 | 0.400 |
Why?
|
| Mice, Inbred NOD | 3 | 2020 | 910 | 0.400 |
Why?
|
| Indoles | 2 | 2014 | 1034 | 0.400 |
Why?
|
| Benzamides | 8 | 2021 | 1882 | 0.390 |
Why?
|
| Humans | 64 | 2024 | 272039 | 0.380 |
Why?
|
| Cytarabine | 5 | 2015 | 2014 | 0.370 |
Why?
|
| Down-Regulation | 3 | 2016 | 2106 | 0.370 |
Why?
|
| Neoplasm Proteins | 7 | 2010 | 3363 | 0.360 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 598 | 0.350 |
Why?
|
| Mutation | 7 | 2024 | 15954 | 0.350 |
Why?
|
| Idarubicin | 2 | 2011 | 459 | 0.330 |
Why?
|
| Aminopyridines | 2 | 2021 | 223 | 0.320 |
Why?
|
| Cell Cycle | 5 | 2018 | 2150 | 0.320 |
Why?
|
| Oligonucleotides, Antisense | 5 | 2013 | 257 | 0.310 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2024 | 3148 | 0.310 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2010 | 211 | 0.310 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2024 | 16628 | 0.300 |
Why?
|
| Epoxy Compounds | 5 | 2020 | 57 | 0.300 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 63 | 0.300 |
Why?
|
| Mitochondria | 5 | 2023 | 1313 | 0.300 |
Why?
|
| Stem Cells | 3 | 2023 | 1236 | 0.300 |
Why?
|
| Masoprocol | 1 | 2007 | 18 | 0.290 |
Why?
|
| CDC2 Protein Kinase | 2 | 2007 | 188 | 0.290 |
Why?
|
| Signal Transduction | 9 | 2017 | 12228 | 0.280 |
Why?
|
| Aniline Compounds | 2 | 2008 | 206 | 0.280 |
Why?
|
| Cell Death | 3 | 2023 | 689 | 0.280 |
Why?
|
| HL-60 Cells | 5 | 2015 | 318 | 0.270 |
Why?
|
| Blotting, Western | 5 | 2014 | 3646 | 0.270 |
Why?
|
| Proteins | 2 | 2005 | 2058 | 0.260 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 1373 | 0.250 |
Why?
|
| Antioxidants | 1 | 2007 | 522 | 0.230 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 7481 | 0.230 |
Why?
|
| Cell Adhesion | 2 | 2017 | 1041 | 0.230 |
Why?
|
| ADP-ribosyl Cyclase 1 | 2 | 2015 | 151 | 0.220 |
Why?
|
| DNA Methylation | 1 | 2014 | 2761 | 0.220 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 96 | 0.220 |
Why?
|
| PPAR alpha | 1 | 2023 | 63 | 0.220 |
Why?
|
| Heterografts | 2 | 2023 | 745 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 1085 | 0.210 |
Why?
|
| Lipid Peroxidation | 1 | 2023 | 164 | 0.210 |
Why?
|
| Phospholipids | 1 | 2023 | 169 | 0.210 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2022 | 28 | 0.200 |
Why?
|
| Dasatinib | 2 | 2024 | 881 | 0.190 |
Why?
|
| Phenylurea Compounds | 1 | 2005 | 600 | 0.190 |
Why?
|
| Imidazoles | 3 | 2015 | 1061 | 0.190 |
Why?
|
| Protein Array Analysis | 2 | 2014 | 505 | 0.180 |
Why?
|
| Stromal Cells | 2 | 2017 | 835 | 0.170 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 1106 | 0.160 |
Why?
|
| Peptidomimetics | 1 | 2019 | 29 | 0.160 |
Why?
|
| U937 Cells | 3 | 2008 | 179 | 0.160 |
Why?
|
| Oxytocics | 1 | 2019 | 33 | 0.160 |
Why?
|
| Male | 16 | 2024 | 129081 | 0.160 |
Why?
|
| Biomarkers, Tumor | 4 | 2020 | 10758 | 0.150 |
Why?
|
| Azacitidine | 2 | 2015 | 1220 | 0.150 |
Why?
|
| Female | 18 | 2024 | 149291 | 0.150 |
Why?
|
| Middle Aged | 13 | 2024 | 90457 | 0.150 |
Why?
|
| Gene Duplication | 1 | 2019 | 433 | 0.150 |
Why?
|
| Myeloproliferative Disorders | 2 | 2024 | 881 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 3 | 2019 | 2399 | 0.140 |
Why?
|
| Coculture Techniques | 2 | 2020 | 631 | 0.140 |
Why?
|
| bcl-X Protein | 2 | 2015 | 199 | 0.140 |
Why?
|
| Thiones | 1 | 2016 | 19 | 0.140 |
Why?
|
| Acute Disease | 5 | 2010 | 2510 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 1720 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 3651 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 621 | 0.130 |
Why?
|
| Gene Expression | 2 | 2017 | 3690 | 0.130 |
Why?
|
| Aged | 9 | 2024 | 73500 | 0.130 |
Why?
|
| Protein Transport | 1 | 2018 | 739 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2021 | 2912 | 0.130 |
Why?
|
| Glycoside Hydrolases | 2 | 1992 | 42 | 0.130 |
Why?
|
| Nitrophenols | 1 | 2015 | 95 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2018 | 834 | 0.120 |
Why?
|
| Auranofin | 1 | 2014 | 36 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 3472 | 0.120 |
Why?
|
| Biphenyl Compounds | 1 | 2015 | 191 | 0.120 |
Why?
|
| Cell Communication | 1 | 2017 | 518 | 0.120 |
Why?
|
| Enzyme Activation | 2 | 2015 | 1831 | 0.110 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2013 | 17 | 0.110 |
Why?
|
| Adult | 10 | 2024 | 81993 | 0.110 |
Why?
|
| Leupeptins | 1 | 2013 | 73 | 0.110 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2013 | 138 | 0.110 |
Why?
|
| Primary Myelofibrosis | 1 | 2021 | 915 | 0.110 |
Why?
|
| Oligochaeta | 1 | 1992 | 1 | 0.110 |
Why?
|
| I-kappa B Proteins | 1 | 2013 | 177 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2011 | 6489 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2017 | 9318 | 0.100 |
Why?
|
| Thiazoles | 2 | 2021 | 725 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2010 | 1842 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2006 | 384 | 0.100 |
Why?
|
| Drug Design | 1 | 2014 | 378 | 0.100 |
Why?
|
| Transplantation, Heterologous | 3 | 2014 | 1086 | 0.100 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 229 | 0.100 |
Why?
|
| Boronic Acids | 1 | 2013 | 355 | 0.100 |
Why?
|
| Bortezomib | 1 | 2013 | 542 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2013 | 451 | 0.090 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2011 | 48 | 0.090 |
Why?
|
| Drug Dosage Calculations | 1 | 2011 | 46 | 0.090 |
Why?
|
| Pyrazines | 1 | 2013 | 511 | 0.090 |
Why?
|
| Caspase 6 | 1 | 2009 | 15 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 1397 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 31071 | 0.080 |
Why?
|
| Pyridines | 1 | 2016 | 1312 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 882 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 1606 | 0.080 |
Why?
|
| Mice, Nude | 4 | 2020 | 4360 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 4372 | 0.080 |
Why?
|
| Cell Movement | 1 | 2016 | 2504 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 2219 | 0.080 |
Why?
|
| Young Adult | 4 | 2024 | 22173 | 0.080 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 94 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2017 | 1781 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 703 | 0.070 |
Why?
|
| Jurkat Cells | 1 | 2007 | 320 | 0.070 |
Why?
|
| Retinoids | 1 | 2006 | 151 | 0.070 |
Why?
|
| Interferon-alpha | 1 | 2010 | 964 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2011 | 1435 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 665 | 0.060 |
Why?
|
| Caspase 9 | 1 | 2006 | 188 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 32759 | 0.060 |
Why?
|
| Biomarkers | 1 | 2017 | 5098 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 569 | 0.060 |
Why?
|
| Recurrence | 2 | 2011 | 4887 | 0.060 |
Why?
|
| Iron | 2 | 2023 | 381 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 190 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 5187 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 3537 | 0.060 |
Why?
|
| Autophagy | 1 | 2010 | 921 | 0.060 |
Why?
|
| DNA, Antisense | 1 | 2003 | 44 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2006 | 682 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 4993 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2006 | 636 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 4350 | 0.050 |
Why?
|
| Prognosis | 3 | 2019 | 22543 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 2470 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2006 | 1146 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 264 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2023 | 319 | 0.050 |
Why?
|
| Smoothened Receptor | 1 | 2021 | 53 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 376 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 6988 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2009 | 2139 | 0.050 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 57 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2006 | 1322 | 0.050 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 87 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 4994 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2022 | 473 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2008 | 1739 | 0.040 |
Why?
|
| Lipids | 1 | 2023 | 661 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 1443 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 263 | 0.040 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2024 | 530 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 983 | 0.040 |
Why?
|
| Cell Division | 1 | 2003 | 2711 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 1966 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 272 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2021 | 497 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 1566 | 0.040 |
Why?
|
| Disease Progression | 2 | 2021 | 6909 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 5105 | 0.040 |
Why?
|
| Nickel | 1 | 2016 | 45 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 15914 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 1011 | 0.030 |
Why?
|
| Aclarubicin | 1 | 2015 | 2 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 196 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2006 | 4195 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2016 | 234 | 0.030 |
Why?
|
| Harringtonines | 1 | 2015 | 93 | 0.030 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2003 | 5788 | 0.030 |
Why?
|
| Proteomics | 1 | 2022 | 1437 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4797 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2014 | 224 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 2598 | 0.030 |
Why?
|
| G(M1) Ganglioside | 1 | 1992 | 11 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 1992 | 70 | 0.030 |
Why?
|
| Glycosphingolipids | 1 | 1992 | 22 | 0.030 |
Why?
|
| Dogs | 1 | 2014 | 1169 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 1439 | 0.030 |
Why?
|
| Hydrolysis | 1 | 1992 | 237 | 0.030 |
Why?
|
| Genes, fos | 1 | 1991 | 58 | 0.020 |
Why?
|
| Transferases | 1 | 1991 | 9 | 0.020 |
Why?
|
| Glycoconjugates | 1 | 1991 | 16 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 584 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1992 | 622 | 0.020 |
Why?
|
| Autophagy-Related Protein 12 | 1 | 2010 | 5 | 0.020 |
Why?
|
| Child | 2 | 2024 | 30577 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 1992 | 358 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1991 | 114 | 0.020 |
Why?
|
| Beclin-1 | 1 | 2010 | 89 | 0.020 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2010 | 50 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 5604 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 5756 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 2496 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1991 | 426 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 33913 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2010 | 94 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 5502 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 2256 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 3417 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1991 | 1035 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 481 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 6208 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 1991 | 1026 | 0.020 |
Why?
|
| K562 Cells | 1 | 2006 | 345 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2009 | 408 | 0.020 |
Why?
|
| Flavonoids | 1 | 2006 | 201 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2006 | 374 | 0.020 |
Why?
|
| Purines | 1 | 2006 | 271 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 6640 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 813 | 0.020 |
Why?
|
| Lysine | 1 | 2006 | 428 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 1972 | 0.010 |
Why?
|
| Glycine | 1 | 2006 | 320 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 455 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 782 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10258 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2085 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 1533 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2008 | 1514 | 0.010 |
Why?
|
| Benzopyrans | 1 | 2002 | 42 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1991 | 4199 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 2974 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 1577 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 10369 | 0.010 |
Why?
|
| Nitriles | 1 | 2002 | 945 | 0.010 |
Why?
|
| Leeches | 1 | 1991 | 3 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1991 | 725 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1991 | 609 | 0.000 |
Why?
|